Filing Details

Accession Number:
0001127602-24-004982
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-14 14:23:30
Reporting Period:
2024-02-13
Accepted Time:
2024-02-14 14:23:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326732 Xencor Inc XNCR Pharmaceutical Preparations (2834) 201622502
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591313 R John Desjarlais C/O Xencor, Inc.
465 N Halstead Street, Suite 200
Pasadena CA 91107
Sr. Vice President & Cso No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-13 68,057 $11.05 215,783 No 4 M Direct
Common Stock Disposition 2024-02-13 54,108 $19.38 161,675 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-02-13 68,057 $0.00 68,057 $11.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,943 2024-02-20 No 4 M Direct
Footnotes
  1. This transaction is pursuant to a 10b5-1 plan.
  2. Underlying option due to expire in February 2024.
  3. Represents the disposition of shares sold to pay option cost and estimated tax liability due upon option exercise.
  4. 25% of the shares subject to the option shall vest on the one year anniversary of February 21, 2014 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested on the four year anniversary of the Vesting Commencement Date.